Important Activities

Scientific Program

Project Matchmaking

Keynote Forum

Stream 7

Stream 8

Stream 9

Stream 10

Plenary Talk

Stream 11

Stream 12

Stream 13

Stream 14

Stream 10 Drug Discovery Chemistry and Smart Drug Delivery

Stream 1001: Medicinal Chemistry and Drug Discovery
Time: 14:45-17:10, Nov 16, 2019(Saturday)
Place: FUNCTION ROOM 4, 3^rd Floor, HOTEL UNIC

Chair: Dr. Stephan Zahn, Scientific Director, Boehringer Ingelheim RCV GmbH & Co KG, Austria

Time

Face On

Speeches and Speakers

14:45-14:50

Chair's Introduction

14:50-15:10

15:10-15:30

Title: Medicinal Chemistry at Boehringer Ingelheim – Challenging Targets – Fragment Based Drug Discovery – Team Science
Dr. Stephan Zahn, Scientific Director, Boehringer Ingelheim RCV GmbH & Co KG, Austria

15:30-15:50

Title: Discovery of a Novel Series of CHK1 Kinase Inhibitors and SAR Mixture Optimization Using the Affinity Selection−mass Spectrometry (AS-MS) Platform
Dr. Xianshu Yang, Principal Scientist, Merck Research Laboratries, Merck & Co., USA

15:50-16:10

Title: Design and Synthesis of Boron-containing Diphenylpyrimidines as Potent BTK and JAK3 Dual Inhibitors
Dr. Yinsheng Zhang, Vice President of Pharmaceutical R&D Institute, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, China

Title: Discovery of Two Ret Kinase Iinhibitors in Clinical Trials for the Treatment of IBS
Dr. Amy Guan, Vice President, Haiyan Pharma of Yangtzi River Pharmaceutical Groups, China

Stream 1002: Innovations in Drug Delivery System and Technology
Time: 13:30-17:10, Nov 16, 2019(Saturday)
Place: FUNCTION ROOM 3, 3^rd Floor, HOTEL UNIC

Chair: Dr. Wei Min Huang, Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore

Time

Face On

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Keynote Speaker:
Title: Formulation Challenges of the Future: How to Address with Manufacturing Technologies and Excipients
Dr. Dieter Lubda, Director, Merck KGaA, Germany

13:55-14:15

Title: Particulate Drug Delivery Systems in Injectables
Dr. Steffen Denzinger, Director Business Development Actives & Formulation, Merck KGaA, Germany 

14:15-14:35

Title: Oral Peptide Delivery by a Novel lipid based System
Dr. Gert Fricker, Director, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Germany

14:35-14:55

Title: Increased Efficiency in Delivery of Pharmaceutical Cannabinoids
Dr. George E. Anastassov, Founder, Chairman of BOD, AXIM Biotechnologies, Inc., USA

14:55-15:15

Title: Disruptive Sublingual lymphatic Delivery of Biologicals
Mr. Thomas SaiYing Ko, CTO, BioLingus GmbH, Switzerland

15:15-15:30

Coffee Break

15:30-15:50

Title: Bioabsorbable Radiopaque Water-Activated Shape Memory Polymeric Device for Temporary Vascular Occlusion in Liver Cancer Treatment
Dr. Wei Min Huang, Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore

15:50-16:10

16:10-16:30